Search results for 'exports'

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

India seeks no enemies but...: Rajnath amid Trump tariff row

India seeks no enemies but...: Rajnath amid Trump tariff row

Rediff.com30 Aug 2025

The defence minister also announced that India has taken up the challenge of developing a powerful indigenous aero-engine, adding that preparations for this critical project are now almost complete and the work will soon be visible.

From 1905 cry to Modi's 'Vocal for Local': NCERT's new Swadeshi lessons

From 1905 cry to Modi's 'Vocal for Local': NCERT's new Swadeshi lessons

Rediff.com3 Oct 2025

Two modules published by the NCERT, Swadeshi: Vocal for Local (for middle stage) and Swadeshi: For a Self-Reliant India (for secondary stage), carry excerpts from the prime minister's Independence Day address in which he stressed that self-reliance would drive India's journey towards a Viksit Bharat.

India's exports marginally up; trade deficit narrows

India's exports marginally up; trade deficit narrows

Rediff.com16 Oct 2024

Snapping the two months slide, the country's merchandise exports rose marginally by 0.5 per cent to $34.58 billion in September while trade deficit narrowed to $20.78 billion. According to official data released on Wednesday, imports increased by 1.6 per cent to $55.36 billion in September compared to $54.49 billion in the year-ago period. The trade deficit, or the gap between imports and exports, was $20.8 billion during the same month last year.

Trump Is Winning Tariff War Hands Down

Trump Is Winning Tariff War Hands Down

Rediff.com18 Aug 2025

Donald Trump's tariffs, meant as political punishment, have avoided the predicted chaos, lifting US growth, weakening rivals, and letting him claim victory in a resilient global economy, observes T T Ram Mohan.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

High tariffs, foreign fund outflows drag Sensex by 272 points

High tariffs, foreign fund outflows drag Sensex by 272 points

Rediff.com29 Aug 2025

Equity benchmark indices Sensex and Nifty fell on Friday, extending their downward journey to the third day, as investors continued to reel under pressure caused by the imposition of high tariffs and relentless foreign fund outflows.

US penalty risk on Russian oil may add $9-11 bn to India's import bill

US penalty risk on Russian oil may add $9-11 bn to India's import bill

Rediff.com3 Aug 2025

India's annual oil import bill could rise by $9-11 billion if the country is compelled to move away from Russian crude in response to US threats of additional tariffs or penalties on Indian exports, analysts said. India, the world's third-largest oil consumer and importer, has reaped significant benefits by swiftly substituting market-priced oil with discounted Russian crude following Western sanctions on Moscow after its invasion of Ukraine in February 2022.

US tariffs: Only Sun Pharma exposed to some headline risk

US tariffs: Only Sun Pharma exposed to some headline risk

Rediff.com28 Sep 2025

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report.

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

Rediff.com8 Aug 2025

The US' move to raise the tariff on most Indian goods to 50 per cent could drag India's GDP growth for FY26 by 35 to 60 basis points, according to various economists. One basis point (bp) is equal to 0.01 per cent.

BEL fires growth salvo with defence orders, new contracts boost revenues

BEL fires growth salvo with defence orders, new contracts boost revenues

Rediff.com29 Sep 2025

The stock of Bharat Electronics (BEL) has risen 10 per cent over the past seven to eight trading sessions, driven by order wins that improve revenue visibility. The gains mark a reversal of a declining trend in its stock price between early July and late August, during which the scrip fell over 13 per cent.

Didn't take action on basis of religion, but...: Rajnath on Op Sindoor

Didn't take action on basis of religion, but...: Rajnath on Op Sindoor

Rediff.com22 Sep 2025

'PoK will be ours on its own. Demands have started being made in PoK, you must have heard sloganeering'

Hope Rises As China Processes Rare-Earths Requests

Hope Rises As China Processes Rare-Earths Requests

Rediff.com28 Jul 2025

China accounts for about 70 per cent of global rare earth mining and nearly 90 per cent of rare earth magnet production, making it a dominant player and giving it significant leverage in global supply chains.

Trump slaps 100% tariffs on imported pharma products

Trump slaps 100% tariffs on imported pharma products

Rediff.com26 Sep 2025

United States President Donald Trump on Friday announced that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies are building production facilities in the US.

US Tariffs Coming Tomorrow!

US Tariffs Coming Tomorrow!

Rediff.com26 Aug 2025

From 12:01 am eastern daylight time on August 27, 2025, higher tariffs will apply to all products of India that are either entered for consumption in the United States or withdrawn from warehouses for consumption.

Trump's Tariffs: Why India Needs To Be Strategic

Trump's Tariffs: Why India Needs To Be Strategic

Rediff.com12 Aug 2025

In trade negotiations, as in chess, sometimes you need to accept a temporary disadvantage to secure a better long-term position, points out Sonal Varma, chief economist (India and Asia ex-Japan) at Nomura.

India tightens grip on global smartphone market by value

India tightens grip on global smartphone market by value

Rediff.com19 Sep 2025

India is slowly expanding its share as the third-largest market for smartphones globally in terms of value, even as countries like China, at the top, and the UK, at fifth, have seen declines, according to global data from Counterpoint Research.

Factors that will guide the markets this week

Factors that will guide the markets this week

Rediff.com31 Aug 2025

Equity markets this week would keenly track the upcoming GST Council meeting, macroeconomic data announcements and trading activity of foreign investors for further movement, analysts said. Moreover, developments related to tariff negotiations, global market trends and auto sales data would also drive investors' sentiment.

Gau Bhakts To Enter Poll Fray In Bihar

Gau Bhakts To Enter Poll Fray In Bihar

Rediff.com23 Sep 2025

'The Bihar assembly polls will open the eyes of everyone once the Gau Bhakts receive votes.'

Will Buy Russian Oil: Sitharaman

Will Buy Russian Oil: Sitharaman

Rediff.com6 Sep 2025

New Delhi 'will have to take a call which supply source suits us the best,' the finance minister said, pointing out that crude oil accounts for the bulk of India's foreign exchange spend.

Reliance sanction compliant; Russian oil benefit capped at 2.1pc of EBITDA

Reliance sanction compliant; Russian oil benefit capped at 2.1pc of EBITDA

Rediff.com5 Sep 2025

Reliance Industries Ltd has consistently remained compliant with international sanctions and is expected to adhere to upcoming measures on Russian oil, analysts said, estimating that oil sourced from Russia contributes just 2.1 per cent to its consolidated EBITDA. Reliance operates the world's largest single location refining complex, with more than half of the capacity exclusively dedicated for exports.

India's energy sector battles taxes, global turmoil

India's energy sector battles taxes, global turmoil

Rediff.com13 Oct 2025

India's brittle energy security is inextricably linked to two opposing paradigms - fossil fuels, and the transition to green energy. The first powers the present; the second paves the way for Viksit Bharat in 2047.

India Eyes Self-Reliance in Rare-Earth Magnet Production

India Eyes Self-Reliance in Rare-Earth Magnet Production

Rediff.com9 Oct 2025

The government plans to establish a fully indigenous manufacturing ecosystem with an annual production capacity of up to 6,000 tonnes. The scheme is expected to run for seven years, according to official documents.

Why Khadi Should Be Part Of Gen Z's Wardrobe

Why Khadi Should Be Part Of Gen Z's Wardrobe

Rediff.com2 Oct 2025

'Khadi is versatile, breathable and timeless. What's missing is consistent innovation and branding. 'If khadi is positioned as both cool and conscious, it can easily sit between denim's everyday appeal and today's comfort-driven trends,' says Designer Swatti Kapoor.

Amid tariff row, US team's India visit for trade deal talks deferred

Amid tariff row, US team's India visit for trade deal talks deferred

Rediff.com17 Aug 2025

Deferment or rescheduling of the meeting assumes significance as the US has announced a staggering 50 per cent duty on Indian goods.

Impact of 50% US tariff would be concentrated in Q2: CEA Nageswaran

Impact of 50% US tariff would be concentrated in Q2: CEA Nageswaran

Rediff.com30 Aug 2025

The 50 per cent US tariff on Indian goods pose a downside risk to growth but the impact is expected to be short-lived for the economy, and consumption demand could see an uptick after the new goods and service tax (GST) rates are implemented which could even offset the external uncertainty, Chief Economic Advisor (CEA) V Anantha Nageswaran reckoned on Friday.

Higher US tariffs may trim GDP growth by 30 bps: Barclays

Higher US tariffs may trim GDP growth by 30 bps: Barclays

Rediff.com31 Jul 2025

The 25 per cent US tariffs, plus a penalty for Russian imports, could dent India's GDP growth by 30 basis points in the current fiscal, but the higher duty is unlikely to significantly affect India's domestic demand-driven economy, Barclays said on Thursday. If the 25 per cent tariff, announced by US President Donald Trump on Wednesday, is implemented from August 1, the effective average US import tariff on Indian goods will rise to 20.6 per cent in trade-weighted terms, as per Barclays estimates.

Exports up 17.25% in Oct; highest in over 2 years

Exports up 17.25% in Oct; highest in over 2 years

Rediff.com14 Nov 2024

India's merchandise exports in October rose by 17.25 per cent to $39.2 billion against $33.43 billion a year ago, according to government data released on Thursday. Imports increased by 3.9 per cent to $66.34 billion in October compared to $63.86 billion in the year-ago period.

Pak PM May Meet Trump Next Week

Pak PM May Meet Trump Next Week

Rediff.com17 Sep 2025

The meeting, expected on September 25 on the sidelines of the UN General Assembly, will also be attended by army chief Field Marshal Asim Munir.

Hyundai unperturbed by rare earth magnet shortage

Hyundai unperturbed by rare earth magnet shortage

Rediff.com30 Jul 2025

Hyundai Motor India on Wednesday said the company is not facing any production issues due to the shortage of rare earth magnets. Replying to a query in the company's earnings conference call, Hyundai Motor India head of investor relations K S Hariharan noted that the company is maintaining an adequate inventory of the rare earth magnets.

AI: '8 Out Of 10 Jobs At Risk'

AI: '8 Out Of 10 Jobs At Risk'

Rediff.com29 Sep 2025

AI will erase outsourcing jobs, redefine skills and disrupt global giants within five years, predicts Vinod Khosla. The IT legend urges young people to become generalists: Adaptable thinkers who can learn quickly, connect dots across disciplines and shift careers as technologies evolve.

Trump Tantrum: 'Present Moment Difficult For India'

Trump Tantrum: 'Present Moment Difficult For India'

Rediff.com20 Aug 2025

'Geopolitically and diplomatically it's a very difficult situation for India.'

How would India become Vishwaguru if...: Sonam Wangchuk's wife

How would India become Vishwaguru if...: Sonam Wangchuk's wife

Rediff.com30 Sep 2025

Talking to reporters in New Delhi, Angmo challenged authorities to an open debate on the allegations, including those suggesting links to Pakistan, and said neither she has been able to contact Wangchuk nor has she been provided with formal documents detailing the charges against him by the administration.

India to take all steps to protect national interest: Goyal on US tariff

India to take all steps to protect national interest: Goyal on US tariff

Rediff.com31 Jul 2025

India will take all necessary steps to safeguard and promote national interest, Commerce and Industry Minister Piyush Goyal said on Thursday, a day after US President Donald Trump announced 25 per cent tariffs plus penalty on domestic exports to America from August 1.

Who prevented military action after 26/11, asks Modi citing Chidambaram

Who prevented military action after 26/11, asks Modi citing Chidambaram

Rediff.com9 Oct 2025

Prime Minister Narendra Modi on Wednesday asked the Congress to tell the nation who prevented India's military response after the 26/11 Mumbai terror attacks linked to Pakistan, and accused the party of weakening the fight against terrorism when in power.

Sensex jumps 555 pts on value buying, strong GDP data

Sensex jumps 555 pts on value buying, strong GDP data

Rediff.com1 Sep 2025

Among Sensex firms, Mahindra & Mahindra, Tata Motors, Trent, Eternal, Asian Paints and Infosys were the major gainers. However, Sun Pharma, ITC, Hindustan Unilever and Titan were among the laggards.

Valuation a key hurdle for auto stocks in short term

Valuation a key hurdle for auto stocks in short term

Rediff.com24 Sep 2025

Multiple tailwinds for the automobile sector, including a cut in goods and services tax (GST) rates, are keeping analysts bullish on auto stocks from a long-term perspective, even as they see the rally running its course in the near term.

Adani Power, Druk Green plan Rs 6K cr hydro project in Bhutan

Adani Power, Druk Green plan Rs 6K cr hydro project in Bhutan

Rediff.com6 Sep 2025

Adani Power on Saturday said it has inked a pact with Bhutan's state-owned utility Druk Green Power to set up a 570MW hydro project entailing investment of Rs 6,000 crore, in the Himalayan Kingdom. As per the pact, Adani Power and Druk Green Power Corp Ltd (DGPC), will initiate the the peaking run-of-river Wangchhu hydroelectric project on a BOOT (Build, Own, Operate, Transfer) model.

Car sales in fast lane in Sep on lower prices post GST rejig

Car sales in fast lane in Sep on lower prices post GST rejig

Rediff.com1 Oct 2025

Auto majors Maruti Suzuki, Tata Motors and Mahindra & Mahindra reported robust sales in September as reduced price tags owing to GST rationalisation led to record demand in the Navaratri period. The month also saw Tata Motors and Mahindra & Mahindra settling at number two and three positions, respectively in vehicle wholesales ahead of Hyundai Motor India.

Will Japan's Iron Lady Deepen India-Japan Ties?

Will Japan's Iron Lady Deepen India-Japan Ties?

Rediff.com15 Oct 2025

As a protege of Shinzo Abe, Takaichi is expected to scale bilateral ties much higher. Trade and investment shall grow. People-to-people contacts shall be scaled up, points out Dr Rajaram Panda.